PDT Partners’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $425K | Buy |
+14,382
| New | +$425K | 0.02% | 545 |
|
|
2023
Q1 | – | Sell |
-25,804
| Closed | -$599K | – | 593 |
|
|
2022
Q4 | $599K | Sell |
25,804
-10,496
| -29% | -$244K | 0.1% | 347 |
|
|
2022
Q3 | $582K | Sell |
36,300
-21,711
| -37% | -$348K | 0.09% | 391 |
|
|
2022
Q2 | $1.03M | Buy |
58,011
+43,207
| +292% | +$766K | 0.09% | 389 |
|
|
2022
Q1 | $301K | Buy |
+14,804
| New | +$301K | 0.03% | 720 |
|
|
2020
Q1 | – | Sell |
-36,390
| Closed | -$749K | – | 684 |
|
|
2019
Q4 | $749K | Sell |
36,390
-7,310
| -17% | -$150K | 0.05% | 334 |
|
|
2019
Q3 | $502K | Sell |
43,700
-11,100
| -20% | -$128K | 0.03% | 340 |
|
|
2019
Q2 | $721K | Buy |
+54,800
| New | +$721K | 0.04% | 278 |
|
|
2016
Q4 | – | Sell |
-23,800
| Closed | -$458K | – | 507 |
|
|
2016
Q3 | $458K | Hold |
23,800
| – | – | 0.03% | 384 |
|
|
2016
Q2 | $282K | Buy |
+23,800
| New | +$282K | 0.02% | 382 |
|